JPS61225108A - Agent for skin application - Google Patents
Agent for skin applicationInfo
- Publication number
- JPS61225108A JPS61225108A JP6618585A JP6618585A JPS61225108A JP S61225108 A JPS61225108 A JP S61225108A JP 6618585 A JP6618585 A JP 6618585A JP 6618585 A JP6618585 A JP 6618585A JP S61225108 A JPS61225108 A JP S61225108A
- Authority
- JP
- Japan
- Prior art keywords
- sulfur
- retinoic acid
- retinol
- skin
- dandruff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 51
- 239000011593 sulfur Substances 0.000 claims abstract description 51
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 50
- 229960005349 sulfur Drugs 0.000 claims abstract description 49
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 48
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 36
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 35
- 229960001727 tretinoin Drugs 0.000 claims abstract description 35
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229960003471 retinol Drugs 0.000 claims abstract description 25
- 235000020944 retinol Nutrition 0.000 claims abstract description 25
- 239000011607 retinol Substances 0.000 claims abstract description 25
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 17
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 3
- 208000001840 Dandruff Diseases 0.000 abstract description 28
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 19
- 206010000496 acne Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000047 product Substances 0.000 abstract description 15
- 230000002265 prevention Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 235000013350 formula milk Nutrition 0.000 abstract 2
- 230000006866 deterioration Effects 0.000 abstract 1
- 238000010525 oxidative degradation reaction Methods 0.000 abstract 1
- 150000003464 sulfur compounds Chemical class 0.000 abstract 1
- 239000000376 reactant Substances 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 210000004761 scalp Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000004299 exfoliation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- -1 mercapto compounds Chemical class 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はレチノイン酸またはレチノールと硫黄との反応
物を有効成分とする皮ふ施用料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a skin application containing a reaction product of retinoic acid or retinol with sulfur as an active ingredient.
この皮ふ施用料は、特にアクネ(いわゆるニキビ)の予
防、治療、処置に有効に働き、また、頭皮に使用してフ
ケを有効に予防することができる。This skin application is particularly effective in the prevention, treatment, and treatment of acne (so-called acne), and can also be used on the scalp to effectively prevent dandruff.
[従来の技術〕
従来、硫黄は皮ふ用軟こう薬剤又は皮ふ用化粧料に配合
して使用されてきたが、この場合硫黄の形態は粉末状又
は分散状であった。[Prior Art] Sulfur has heretofore been used in combination with skin ointments or skin cosmetics, but in this case the sulfur has been in the form of powder or dispersion.
[発明が解決しようとする問題点1
このため従来品を皮ふに施用したとき、大部分の硫黄は
単に皮ふ表面を覆う役割を果たすにとどまり、極く一部
の硫黄しか薬効ないし化粧効果の発現に関与しなかった
。したがって、従来品に満足のいく効果を期待すること
はできず、強いて効果を挙げようとすると使用量を多く
する必要があり、その結果、皮ふ刺激により炎症を起す
おそれがあった。また、粉末状の硫黄は皮ふ表面上で、
いわゆるザラツキを生し使用性がよくないという欠点も
あった。[Problem to be solved by the invention 1] Therefore, when conventional products are applied to the skin, most of the sulfur merely serves to cover the skin surface, and only a small portion of the sulfur has medicinal or cosmetic effects. was not involved. Therefore, it is not possible to expect a satisfactory effect from conventional products, and in order to obtain a strong effect, it is necessary to increase the amount of use, and as a result, there is a risk of inflammation due to skin irritation. In addition, powdered sulfur is on the skin surface,
It also had the disadvantage that it produced so-called roughness and was not easy to use.
[問題点を解決するための手段]
本発明者らは、このような欠点を解消すべく研究を行っ
た結果、レチノイン酸またはレチノールと硫黄との反応
物を有効成分として使用すると前記欠点のない有効な皮
ふ施用料が得られることを見出し、本発明を完成させる
に至った。[Means for Solving the Problems] As a result of research conducted by the present inventors in order to eliminate such drawbacks, the present inventors found that using a reaction product of retinoic acid or retinol with sulfur as an active ingredient eliminates the above-mentioned drawbacks. It was discovered that an effective skin application material could be obtained, and the present invention was completed.
すなわち、本発明は、下記の少なくとも1種を有効成分
として含有してなる皮ふ施用材である。That is, the present invention is a skin application material containing at least one of the following as an active ingredient.
A、レチノイン酸と硫黄の反応物。A, reaction product of retinoic acid and sulfur.
B、レチノールと硫黄の反応物。B, reaction product of retinol and sulfur.
C,レチノイン酸とレチノールと硫黄の反応物。C, reaction product of retinoic acid, retinol and sulfur.
本発明の皮ふ施用材は、皮ふ外用剤例えば軟こうとして
、又は皮ふ化粧料例えばクリーム、頭皮用材として皮ふ
に適用される。特に、このものは皮ふに適用してアクネ
の予防、治療、処置に有効であり、また頭皮に適用して
フケの防止に著効を発揮するので、皮ふ施用材として極
めて有用なものである。The skin application material of the present invention is applied to the skin as an external skin preparation, such as an ointment, or as a skin cosmetic, such as a cream, or a scalp material. In particular, this product is extremely useful as a skin application material since it is effective in preventing, treating, and treating acne when applied to the skin, and it is extremely effective in preventing dandruff when applied to the scalp.
また、従来、レチノイン酸またはレチノールは角質剥離
作用を有することが知られているが、皮ふに対する刺激
が強すぎることから使用例が少なかった。しかし、本発
明に係る硫黄との化合物は皮ふに対する刺激がいちじる
しく改善されている。Furthermore, although retinoic acid or retinol has been known to have a keratin exfoliating effect, it has been rarely used because it is too irritating to the skin. However, the compound with sulfur according to the present invention has significantly improved skin irritation.
レチノイン酸またはレチノールの優秀な角質剥離作用を
有効に利用できる点でも本発明の価値は大きい。The present invention is also of great value in that it can effectively utilize the excellent exfoliating action of retinoic acid or retinol.
本発明で用いるレチノイン酸は化学名、3,7−シメチ
ルー9− (2,6,6−1□リメチル−1=シクロヘ
キセン−1−イル)−2,4,6,8−ノナテトラエン
酸であり、下記の構造を有する。The chemical name of retinoic acid used in the present invention is 3,7-dimethyl-9-(2,6,6-1□limethyl-1=cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, It has the following structure.
また、本発明で用いるレチノールは下記の構造を有する
。Moreover, retinol used in the present invention has the following structure.
両者は、いずれも角質剥離作用を有し、レチノイン酸は
米国などで臨床アクネ薬などに小数ではあるが配合され
ている例がある。Both have a keratin exfoliating effect, and retinoic acid is included in a small number of clinical acne drugs in the United States and other countries.
本発明の皮ふ施用材は、係るレチノイン酸またはレチノ
ールと硫黄との反応物、あるいはレチノイン酸とレチノ
ールと硫黄との反応物のいずれか一種、または二種以上
を含んでなる。The skin application material of the present invention comprises one or more of the above-mentioned reaction product of retinoic acid or retinol and sulfur, or the reaction product of retinoic acid, retinol and sulfur.
反応は、レチノイン酸またはレチノールと硫黄、あるい
はレチノイン酸とレチノールの混合物と硫黄とを、通常
130〜220℃、望ましくは15〜150℃で触媒の
存在下又は不存在下で行う。レチノイン酸またはレチノ
ール、あるいはレチノイン酸とレチノールの混合物10
0重量部に対し硫黄を通常0.1〜150重量部、望ま
しくは0.5〜50重量部使用する。The reaction is carried out between retinoic acid or retinol and sulfur, or a mixture of retinoic acid and retinol and sulfur, usually at 130 to 220°C, preferably at 15 to 150°C, in the presence or absence of a catalyst. Retinoic acid or retinol or a mixture of retinoic acid and retinol 10
Sulfur is usually used in an amount of 0.1 to 150 parts by weight, preferably 0.5 to 50 parts by weight.
反応物は、レチノイン酸またはレチノールの不飽和結合
の部位における硫黄による架橋反応により生成したもの
が主体をなすが、他の硫化反応物例えばメルカプト化物
、さらには未反応物を含んでいてもよい。The reactants are mainly those produced by a crosslinking reaction with sulfur at the unsaturated bond sites of retinoic acid or retinol, but may also contain other sulfurized reactants, such as mercapto compounds, and even unreacted products.
例えばレチノイン酸80重量部に硫黄20重量部を反応
させた反応物は、褐色の固体(室温)であり、このもの
をGPC(ゲルろ過クロマトグラフィー)NMR(核磁
気共鳴)、質量分析、赤外スペクトルなどで調べた結果
、二重結合の部位において硫黄により2分子のレチノイ
ン酸が結合した架橋反応物、3分子のレチノイン酸が結
合した架橋反応物、4分子のレチノイン酸が結合した架
橋反応物、さらに未反応物を含むことが確認された。For example, the reaction product obtained by reacting 80 parts by weight of retinoic acid with 20 parts by weight of sulfur is a brown solid (at room temperature), and this product can be analyzed by GPC (gel filtration chromatography), NMR (nuclear magnetic resonance), mass spectrometry, infrared As a result of spectroscopy, we found that a cross-linked reaction product had two molecules of retinoic acid bound to each other by sulfur at the double bond site, a cross-linked reaction product had three molecules of retinoic acid bound to each other, and a cross-linked reaction product had four molecules of retinoic acid bound to each other at the double bond site. It was confirmed that it also contained unreacted substances.
本発明における反応物は、粉末硫黄と異なり、エタノー
ルに熔解し、種々の界面活性剤によって可溶化又は乳化
される特性を有し、また、油性成分例えばオリーブ油等
に対し酸化防止能を有する。The reactant in the present invention, unlike powdered sulfur, has the property of being dissolved in ethanol, solubilized or emulsified by various surfactants, and has antioxidant ability against oily components such as olive oil.
本発明の皮ふ施用材は有効成分として前記反応物を合有
し、他に通常の成分を配合してなるものである。通常の
成分としては油分、水、乳化剤、保湿剤、粉末、増粘剤
、酸化防止剤、防腐剤、香料等を挙げることができる。The skin application material of the present invention contains the above-mentioned reactant as an active ingredient, and contains other usual ingredients. Typical ingredients include oil, water, emulsifiers, humectants, powders, thickeners, antioxidants, preservatives, fragrances, and the like.
量関係について、有効成分の反応物の配合量は全量10
0重量部に対し0601〜20、好ましくは0.1〜l
O重量部である。Regarding the amount relationship, the total amount of reactants of active ingredients is 10
0601 to 20, preferably 0.1 to 1 per 0 parts by weight
O parts by weight.
[発明の効果]
本発明の皮ふ施用材にあっては、粉末硫黄と異なり、硫
黄の大部分は薬効ないし化粧効果の発現に関与し、した
がって、硫黄量も少なくてずみ、皮ふ炎症等の副作用を
起こすことがなく、また、皮ふ上でザラツキを生しるこ
とがなく使用感が良好である。そして驚くべきことに、
本発明の皮ふ施用料は頭皮に使用して特にフケ、アクネ
等を顕著に防止することができる。本発明の皮ふ施用料
は、油性成分が配合されている場合に油の酸化変性によ
る品質低下を起こすことがない。また、レチノイン酸あ
るいはレチノールの皮ふ刺激性も大幅に緩和されている
。[Effects of the Invention] Unlike powdered sulfur, in the skin application material of the present invention, most of the sulfur is involved in the expression of medicinal or cosmetic effects, and therefore the amount of sulfur is small and there are no side effects such as skin irritation. It does not cause irritation or roughness on the skin, and has a good feeling of use. And surprisingly,
The skin preparation of the present invention can be used on the scalp to significantly prevent dandruff, acne, etc. When the skin application composition of the present invention contains an oily component, the quality does not deteriorate due to oxidative denaturation of the oil. Furthermore, the skin irritation of retinoic acid or retinol is significantly alleviated.
次に、フケの防止効果について述べる。Next, we will discuss the dandruff prevention effect.
フケの防止効果はウサギと人に対する使用テストの結果
により判定した。The preventive effect on dandruff was determined based on the results of use tests on rabbits and humans.
fl、l ウサギに対する使用テスト動物としてウサ
ギを用い、ウサギの両側の耳翼の外側にオレイン酸の2
0%メタノール7′8液を塗布した。ついで、オレイン
酸塗布後、片側の耳翼の外側に設定濃度のレチノイン酸
−硫黄反応物のメタノール溶液を塗布した。fl, l Use on rabbits Rabbits were used as test animals.
A 0% methanol 7'8 solution was applied. After applying oleic acid, a methanol solution of a retinoic acid-sulfur reactant at a predetermined concentration was applied to the outside of one ear wing.
この操作を1日1回延べ4日間行った。オレイン酸のみ
塗布した耳翼はフケ状物質が形成されたのに対して、オ
レイン酸とレチノイン酸−硫黄反応物を塗布した耳翼で
は、レチノイン酸−硫黄反応物の濃度に比例して、フケ
状物質の形成が認められなくなった。This operation was performed once a day for a total of 4 days. Dandruff-like substances were formed in the ear wings to which only oleic acid was applied, whereas dandruff was formed in the ear wings to which oleic acid and the retinoic acid-sulfur reactant were applied, in proportion to the concentration of the retinoic acid-sulfur reactant. The formation of a similar substance was no longer observed.
この結果を表(1)に示した。The results are shown in Table (1).
(以下余白) 表fi+ [フケ状物質の形成] (注1)+:ニッケ物質の形成が認められる。(Margin below) Table fi+ [Formation of dandruff-like substance] (Note 1) +: Formation of nickel substance is observed.
±:ニッケ物質の形成がほとんど認められない。±: Formation of nickel substance is hardly observed.
m:フケ状物質の形成が認められない。m: No formation of dandruff-like substance is observed.
(注2)隘5は比較例
(2)人に対する使用テスト
下記表(2)のとおり、レチノイン酸−硫黄反応物、レ
チノール−硫黄反応物を各配合したシャンプー及びヘア
トニックを調製し、フケ防止効果を検討した。(Note 2) No. 5 is a comparative example (2) Human use test As shown in the table (2) below, shampoos and hair tonics containing retinoic acid-sulfur reactants and retinol-sulfur reactants were prepared to prevent dandruff. We examined the effects.
対象者として22〜39才のフケ症の男性40名を選び
、各試料につき10名づつ計40名についてテストを行
った。Forty men with dandruff between the ages of 22 and 39 were selected as subjects, and tests were conducted on a total of 40 men, 10 for each sample.
シャンプー試料は洗髪時に、ヘアトニック試料は洗髪後
のみ1回使用することとし、試験開始前のフケ量と1ケ
月間の試験終了時の洗髪2日目のフケ量を比較し、試験
終了時のフケ量が少ない場合をフケ防止効果ありとし、
フケ量が変化ない場合、及び逆に増加した場合をフケ抑
制効果なしと判定した。The shampoo sample was used once when washing the hair, and the hair tonic sample was used only once after washing the hair.The amount of dandruff before the start of the test was compared with the amount of dandruff on the second day of hair washing at the end of the one-month test, and the amount of dandruff at the end of the test was compared. If the amount of dandruff is small, it is considered to be effective in preventing dandruff.
If the amount of dandruff did not change or if it increased, it was determined that there was no dandruff suppressing effect.
電気掃除機を用いて頭部を吸引し、採取したフケの蛋白
質量を測定して下記表(2)に示す結果を得た。The head was suctioned using a vacuum cleaner, and the protein content of the collected dandruff was measured, and the results shown in Table (2) below were obtained.
表(2)
さらに、アクネの治療効果について述べる。アクネは、
脂腺の分泌活動が盛んになり、毛孔に角化増殖が起って
毛孔が塞がれるといわれている。Table (2) Furthermore, the therapeutic effects on acne will be described. Acne is
It is said that the secretory activity of the sebaceous glands increases and keratinization occurs in the pores, causing them to become clogged.
さらに炎症を起こす原因はアクネ菌によって皮脂が分解
して生ずる遊離脂肪酸の刺激であるともいわれる。した
がって現在アクネの治療にはアクネ菌に対する殺菌作用
をもつ殺菌剤や毛孔を開口させる角質剥離等がよく用い
られている。Furthermore, it is said that the cause of inflammation is the stimulation of free fatty acids produced when sebum is decomposed by P. acnes. Therefore, currently, in the treatment of acne, disinfectants that have a bactericidal effect against acne bacteria and exfoliation that opens pores are often used.
そこで本発明品のアクネに対する有効性を確認すること
を目的とし角質剥離作用を調べた。Therefore, in order to confirm the effectiveness of the product of the present invention against acne, the keratin exfoliating effect was investigated.
(1)アクネ閑に対する殺菌テスト
アクネ菌(propionibacterium ac
nes、当研究所分離株、約5 X 108cells
/ mQ)を試料とリン酸緩衝液(pH7,0)中で
混合した。この際、試料のレチノイン酸−硫黄反応物ま
たはレチノール−硫黄反応物は水に不溶であるので、2
%のツイーン80を添加し、分散状態にして試験を行っ
た。(1) Bactericidal test against acne bacteria Propionibacterium ac
nes, isolated from our laboratory, approximately 5 x 108 cells
/mQ) was mixed with the sample in phosphate buffer (pH 7,0). At this time, since the sample retinoic acid-sulfur reactant or retinol-sulfur reactant is insoluble in water,
% of Tween 80 was added and the test was conducted in a dispersed state.
60分後に0.1−をサンプリングし、1/100倍に
希釈した。そのl&CA M寒天平板培地(日水製薬株
式会社)にその菌体の0.1−を接種し、37°Cで4
日間嫌気的に培養した。生じたコロニーの生菌数を測定
し、試料濃度θ%のときの生菌数に対する割合を計算し
、その値より死滅率を出し各試料の殺菌効果を比較した
。結果は下記表(3)のとおりであった。After 60 minutes, 0.1- was sampled and diluted to 1/100 times. The L&CAM agar plate medium (Nissui Pharmaceutical Co., Ltd.) was inoculated with 0.1- of the bacteria, and incubated at 37°C for 4 hours.
The cells were cultured anaerobically for 1 day. The number of viable bacteria in the resulting colony was measured, the ratio to the number of viable bacteria when the sample concentration was θ% was calculated, and the killing rate was determined from that value to compare the bactericidal effects of each sample. The results were as shown in Table (3) below.
(以下余白)
表(3)
(注)陽1、陽6は比較例
(2)角質剥離テスト
角質に特異的に結合するダンシル(dansyl)クロ
ライドをマーカとしてテストを行った。(Margins below) Table (3) (Note) Positive 1 and Positive 6 are Comparative Example (2) Keratin exfoliation test The test was conducted using dansyl chloride, which specifically binds to stratum corneum, as a marker.
5%ダンジルクロライド(基剤、白色ワセリン)100
μlをパンチテスト用絆創膏(直径1cm)に薄く塗り
、このものをヘアレスマウス(♀体重10〜20g )
25匹の背部に24時間閉塞塗布したのち角質層を螢
光染色した。次に、各種濃度の試料50μlをそれぞれ
1日1回螢光部に塗布した。判定は暗室で長波長紫外線
下既存角質層の螢光が消失した日を終点とし、螢光が消
失するのに要した日数(25匹の平均)により試料の角
質剥離効果を測定した。結果は下記表(4)に示すとお
りであった。5% Danzyl chloride (base, white petrolatum) 100
Apply a thin layer of μl onto a punch test bandage (1 cm in diameter) and apply this to a hairless mouse (♀ weight 10-20 g).
After occlusive application was applied to the backs of 25 animals for 24 hours, the stratum corneum was fluorescently stained. Next, 50 μl of each sample at various concentrations was applied to the fluorescent area once a day. The end point of the judgment was the day when the fluorescence of the existing stratum corneum disappeared under long wavelength ultraviolet rays in a dark room, and the exfoliation effect of the sample was measured by the number of days required for the fluorescence to disappear (average of 25 animals). The results were as shown in Table (4) below.
(以下余白)
表(4)
(以下余白)
」二記表(4)の結果から、本発明例の場合が比較例に
比し、螢光消失所要日数が少なく、アクネ患部を開口す
る角質剥離がすみやかに起こり、したがってアクネの治
療効果において優れていることがわかる。(Hereinafter in the margins) Table (4) (Hereinafter in the margins) From the results in Table (4), it can be seen that in the case of the invention example, the number of days required for the fluorescence to disappear is shorter than in the comparative example, and the exfoliation that opens the acne-affected area is effective. It can be seen that this treatment occurs quickly, and therefore has an excellent therapeutic effect on acne.
以上から明らかなように、本発明の皮ふ施用材は優れた
フケ防止効果とアクネ治療効果を有するものである。As is clear from the above, the skin application material of the present invention has excellent dandruff prevention effects and acne treatment effects.
[実施例] 以下、本発明の実施例と合成例を示す。[Example] Examples and synthesis examples of the present invention are shown below.
実施例1 (乳液の製造)
(A)の成分 配合量(重量%)セタノ
ール 1.5ステアリン酸
1.0パルミチン酸
0.5液状ラノリン 1.
0スクワラン 2.0ミリスチ
ン酸イソプロピル 1.0モノステアリン酸
グリセリル 1,5
ツイーン20 0.5レチノイ
ン酸−
10%硫黄反応物 0.5
防腐剤及び香料 適量(B)の成分
プロピレングリコール 3.0ポリエチレ
ングリコール400 2.0トリエタノールアミ
ン 1.0ネ青製氷
84.5上記(A)の各成
分を混合して混合物を得た。Example 1 (Manufacture of emulsion) Component (A) Amount (wt%) Setanol 1.5 Stearic acid
1.0 palmitic acid
0.5 Liquid Lanolin 1.
0 Squalane 2.0 Isopropyl myristate 1.0 Glyceryl monostearate 1,5 Tween 20 0.5 Retinoic acid - 10% sulfur reactant 0.5 Preservatives and fragrances Proper amount (B) ingredient Propylene glycol 3.0 Polyethylene Glycol 400 2.0 Triethanolamine 1.0 N Blue Ice Making
84.5 The components of (A) above were mixed to obtain a mixture.
別に、同様にして(B)の混合物を得た。(A)の混合
物及び(B)の混合物を各別に70℃に加熱溶解し、(
A)の混合物を(B)の混合物の中に加え、乳化機によ
り乳化したのち熱交換、冷却した乳液を製造した。Separately, a mixture (B) was obtained in the same manner. The mixture of (A) and the mixture of (B) were individually heated and dissolved at 70°C, and (
The mixture of A) was added to the mixture of (B) and emulsified using an emulsifier, followed by heat exchange and cooling to produce a milky lotion.
この乳液はアクネの治療とフケの防止に著効を示した。This emulsion was highly effective in treating acne and preventing dandruff.
実施例2(クリームの製造)
(A)の成分 配合量(重量%)セタノ
ール 4.0ステアリンM
’ 2.0ワセリン
4.0流動パラフイン
10.0ミリスチン酸イソプロピル 5.
0モノステアリン酸
グリセリル 3.0
レチノイン酸−
20%硫黄反応物 1.0
(B)の成分
グリセリン 5.0プロピレング
リコール 5.0水酸化カリウム
0.2楕製水
6o、8実施例1と同様にしてクリームを製造した。Example 2 (Manufacture of cream) Ingredients (A) Amount (wt%) Cetano 4.0 Stearin M
'2.0 Vaseline
4.0 liquid paraffin
10.0 Isopropyl myristate 5.
0 Glyceryl monostearate 3.0 Retinoic acid - 20% sulfur reactant 1.0 Component (B) Glycerin 5.0 Propylene glycol 5.0 Potassium hydroxide
0.2 oval water
6o, 8A cream was produced in the same manner as in Example 1.
このものもアクネの治療とフケの防止に著効を示した。This product also showed remarkable efficacy in treating acne and preventing dandruff.
実施例3 (クリームの製造)
(A>の成分 配合量(重量%)セタノ
ール 4.0ステアリンr!1
)2.0
ワセリン 4.0流動パラ
フイン 10.0ミリスヂン酸イソプ
ロピル 5.0モノステアリン酸
グリセリル 3.0
レチノール−
20%硫黄反応物 1.5
(B)の成分
グリセリン 5.0プロピレング
リコール 5.0水酸化カリウム
0.2精製水
60.3実施例1と同様にしてクリームを製造した。こ
のものもアクネの治療とフケの防止に著効を示した。Example 3 (Manufacture of cream) (Ingredients A> Blending amount (wt%) Cetanol 4.0 Stearin r!1
) 2.0 Vaseline 4.0 Liquid paraffin 10.0 Isopropyl myrisudate 5.0 Glyceryl monostearate 3.0 Retinol - 20% sulfur reactant 1.5 Component of (B) Glycerin 5.0 Propylene glycol 5.0 potassium hydroxide
0.2 Purified water
60.3 A cream was prepared in the same manner as in Example 1. This product also showed remarkable efficacy in treating acne and preventing dandruff.
実施例4 (クリーム状洗浄料)
(A)の成分 配合量(重量%)ステア
リン酸 6.0パルミチン酸
10.0ミリスチン酸
10.。Example 4 (Cream detergent) Ingredients (A) Amount (wt%) Stearic acid 6.0 Palmitic acid
10.0 myristic acid
10. .
ラウリン酸 8.0モノステア
リン酸
グリセリル 2.0
グリセリン 20.0プロピレング
リコール 10.0レチノイン酸−
20%硫黄反応物 0.5
香料 適量(B)の成分
水酸化カリウム 7.OIi製氷
26.5実施例1と同様に
してクリーム状洗浄利(頭皮施用材)を製造した。この
ものはフケの防止に著効を示した。Lauric acid 8.0 Glyceryl monostearate 2.0 Glycerin 20.0 Propylene glycol 10.0 Retinoic acid - 20% sulfur reactant 0.5 Fragrance Appropriate amount (B) component Potassium hydroxide 7. OIi ice making
26.5 A creamy cleansing product (material for scalp application) was produced in the same manner as in Example 1. This product was highly effective in preventing dandruff.
実施例5(軟こう)
成分 配合量(重量%)固体パ
ラフィン 10.0ピースワツクス
l000スクワラン
10.0レチノイン酸−
10%硫黄反応物 1.0
香料 適量ワセリン
69.0上記底分を混合し、混
合物を80°Cに加熱溶解した後、攪拌冷却を行い軟こ
うを得た。このものはアクネの治療に著効を示した。Example 5 (Oint) Ingredients Amount (wt%) Solid paraffin 10.0 piece wax
l000 squalane
10.0 Retinoic acid - 10% sulfur reactant 1.0 Fragrance Appropriate amount Vaseline
69.0 The above bottoms were mixed, and the mixture was heated and dissolved at 80°C, and then cooled with stirring to obtain an ointment. This product was highly effective in treating acne.
実施例6 (シャンプー)
成分 配合量(重量%)ソジウ
ム・ポリオキシエチ
レン(2)ラウリルエーテルサ
ルフェート 25.0ヤシ油
脂肪酸エタノール
アミド 5.0
レチノイン酸−
20%硫黄反応物 0.5
防腐剤・香料 適量精製水
69.5実施例6と同様にして
シャンプーを得た。このものは頭皮に施用してフケの防
止に著効を示した。Example 6 (Shampoo) Ingredients Amount (wt%) Sodium polyoxyethylene (2) Lauryl ether sulfate 25.0 Coconut oil fatty acid ethanolamide 5.0 Retinoic acid - 20% sulfur reactant 0.5 Preservative/Fragrance Appropriate amount of purified water
69.5 A shampoo was obtained in the same manner as in Example 6. This product was applied to the scalp and showed remarkable effectiveness in preventing dandruff.
実施例7 (リンス)
(A)の成分 配合量(重量%)セタノ
ール 2.0モノステアリン酸
グリセリル 3.0
レチノイン酸−
20%硫黄反応物 1.0
防腐剤・香料 適量(B)の成分
塩化ステアリル
トリメチルアンモニウム 2.5プロピレング
リコール 7.0精製水
84.5実施例1と同様にしてリンスを得た
。このものも頭皮に施用してフケの防止に著効を示した
。Example 7 (Rinse) Ingredients (A) Amount (% by weight) Setanol 2.0 Glyceryl monostearate 3.0 Retinoic acid - 20% sulfur reactant 1.0 Preservative/Fragrance Appropriate amount Ingredient (B) Chloride Stearyltrimethylammonium 2.5 Propylene glycol 7.0 Purified water
84.5 A rinse was obtained in the same manner as in Example 1. This product also showed remarkable efficacy in preventing dandruff when applied to the scalp.
実施例8 (ヘアトニック)
エチルアルコール55gにレチノインM−20%硫黄反
応物0.5g、ニソコールHC0−60,1,0g及び
香料を適当量室温下に溶解してアルコール相を得た。別
に精製水42.5gにグリセリン1.0g及び色素を適
当量、加熱下に溶解し冷却した。得た水相に前記アルコ
ール相を加え可溶化してヘアト二ソクを得た。Example 8 (Hair Tonic) Appropriate amounts of Retinoin M-20% sulfur reactant 0.5 g, Nisocol HC0-60, 1.0 g, and perfume were dissolved in 55 g of ethyl alcohol at room temperature to obtain an alcohol phase. Separately, 1.0 g of glycerin and appropriate amounts of the pigment were dissolved in 42.5 g of purified water under heating and cooled. The alcohol phase was added to the obtained aqueous phase to solubilize it to obtain hair tonisoku.
このものは頭皮に施用してフケの防止に著効を示した。This product was applied to the scalp and showed remarkable effectiveness in preventing dandruff.
合成例1 (レチノイン酸−20%硫黄反応物の合成)
レチノイン酸80gに硫黄粉末20gを加え、窒素気流
下150〜160°Cで約2時間反応を行い、褐色固体
を得た。Synthesis Example 1 (Synthesis of retinoic acid-20% sulfur reactant)
20 g of sulfur powder was added to 80 g of retinoic acid, and the reaction was carried out at 150 to 160° C. for about 2 hours under a nitrogen stream to obtain a brown solid.
合成例2 (レチノイン酸−10%硫黄反応物の合成)
レチノイン酸90gに硫黄粉末logを加え、合成例1
と同様にして褐色固体を得た。Synthesis Example 2 (Synthesis of retinoic acid-10% sulfur reactant)
Synthesis Example 1 by adding log sulfur powder to 90 g of retinoic acid.
A brown solid was obtained in the same manner as above.
合成例3 (レチノール−5%硫黄反応物の合成)レチ
ノール95gに硫黄粉末5gを加え、合成例1と同様に
して褐色固体を得た。Synthesis Example 3 (Synthesis of retinol-5% sulfur reactant) 5 g of sulfur powder was added to 95 g of retinol, and a brown solid was obtained in the same manner as in Synthesis Example 1.
合成例4 (レチノール−20%硫黄反応物の合成)レ
チノール80gに硫黄粉末20gを加え、合成例1と同
様にして褐色固体を得た。Synthesis Example 4 (Synthesis of retinol-20% sulfur reactant) 20 g of sulfur powder was added to 80 g of retinol, and a brown solid was obtained in the same manner as in Synthesis Example 1.
Claims (1)
なる皮ふ施用料。 A、レチノイン酸と硫黄の反応物。 B、レチノールと硫黄の反応物。 C、レチノイン酸とレチノールと硫黄の反応物。(1) A skin preparation containing at least one of the following as an active ingredient. A, reaction product of retinoic acid and sulfur. B, reaction product of retinol and sulfur. C, reaction product of retinoic acid, retinol, and sulfur.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6618585A JPS61225108A (en) | 1985-03-29 | 1985-03-29 | Agent for skin application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6618585A JPS61225108A (en) | 1985-03-29 | 1985-03-29 | Agent for skin application |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61225108A true JPS61225108A (en) | 1986-10-06 |
Family
ID=13308528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6618585A Pending JPS61225108A (en) | 1985-03-29 | 1985-03-29 | Agent for skin application |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61225108A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040043703A (en) * | 2002-11-16 | 2004-05-27 | (주)라렌드몽드 | Retinoid containing chemical peeling agent |
-
1985
- 1985-03-29 JP JP6618585A patent/JPS61225108A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040043703A (en) * | 2002-11-16 | 2004-05-27 | (주)라렌드몽드 | Retinoid containing chemical peeling agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5470876A (en) | Topical sod for treating hair loss | |
GB2130486A (en) | Anti-acne compositions based on benzoyl peroxide | |
JPH11501954A (en) | Use of octoxyglycerin as an active agent for treating seborrhea and / or acne in cosmetic and / or dermatological compositions | |
JP2005524651A (en) | Topical dapsone for the treatment of acne | |
JP2878353B2 (en) | External preparation for skin | |
JPH11269034A (en) | Skin prepafation for external use for improving acne | |
US6977081B1 (en) | Facial cream composition containing allantoin | |
JP2640101B2 (en) | External preparation for skin | |
JP2694756B2 (en) | Cosmetics containing divalent and trivalent iron salts | |
JP3568983B2 (en) | Hair restorer | |
JP2001288046A (en) | Composition for scalp and hair | |
KR100610951B1 (en) | Composition for Skin-antiacne | |
JPS61225108A (en) | Agent for skin application | |
JPS63183518A (en) | Composition for hair | |
JP2566792B2 (en) | Hair growth and hair growth promoter | |
JPS61171414A (en) | Skin cream | |
JP3624318B2 (en) | Hair nourishing agent | |
JPS61171409A (en) | Skin cream | |
JPS61171408A (en) | Skin cream | |
JPS6360909A (en) | Skin drug for external use | |
JPH10265365A (en) | External preparation for skin for pimple | |
JPS60202813A (en) | Treatment of skin | |
JPS61238715A (en) | Hair cosmetic | |
JPH0465044B2 (en) | ||
JPS6322506A (en) | External preparation for skin |